Millennium Health (PRIVATE.MILLENIUMHEALTH)

Overall impact
B (65)

Commentary

Millennium Health is a strong overall performer. With a 'B' rating of 65.3 for overall impact (74th percentile compared to all companies), Millennium Health ranks 39th out of 76 industry peers, behind IMAC, Enzo Biochem, Invitae and 35 others, and ahead of Check-Cap, Organovo, Joinn Laboratories and 34 others. On top material causes for Millennium Health's industry (Healthcare Software & Services), Millennium Health performs well in Child and Maternal Health (82.9 score), Access to Affordable Healthcare (89.3), Quality Lifelong Education (95.3) and 4 other causes where it received an 'A' score and performs poorly in Accountable Institutions (18.3 score), Decent, Safe Work Opportunities (26.3) and Accountable Institutions (26.7).
Impact
Cause PRIVATE.MILLENIUMHEALTH
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2007
Employees
500
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Health Care Delivery
Headquarters
California, United States
Share classes
PRIVATE.MILLENIUMHEALTH
Description
New Millennium Holdco Inc along with its subsidiaries provides health solutions. It provides timely, accurate information to the patients. The company's service offering includes Test Offerings, Millennium OFT, Millennium UDT, Millennium PGT, and others.
Material causes
Ethos considers the following causes material for Millennium Health, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.